<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ro">
	<id>https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=Rocket_Pharmaceuticals%2C_Inc.</id>
	<title>Rocket Pharmaceuticals, Inc. - Revizia istoricului</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tradeville.ro/index.php?action=history&amp;feed=atom&amp;title=Rocket_Pharmaceuticals%2C_Inc."/>
	<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=Rocket_Pharmaceuticals,_Inc.&amp;action=history"/>
	<updated>2026-04-06T22:15:52Z</updated>
	<subtitle>Istoricul versiunilor pentru această pagină din wiki</subtitle>
	<generator>MediaWiki 1.39.2</generator>
	<entry>
		<id>https://wiki.tradeville.ro/index.php?title=Rocket_Pharmaceuticals,_Inc.&amp;diff=437905&amp;oldid=prev</id>
		<title>Admin: Pagină nouă: Pagina dedicata companiei Rocket Pharmaceuticals, Inc. listata cu simbolul US.RCKT  ==Descriere companie== Rocket Pharmaceuticals, Inc. (https://www.rocketpharma.com/) is a clinical-stage, multi-platform biotechnology company that is focused on the development of gene therapies for rare and devastating diseases. The Company’s clinical-stage ex vivo lentiviral vector (LVV) programs include: Fanconi Anemia (FA), is a genetic defect in the bone marrow that reduces production o...</title>
		<link rel="alternate" type="text/html" href="https://wiki.tradeville.ro/index.php?title=Rocket_Pharmaceuticals,_Inc.&amp;diff=437905&amp;oldid=prev"/>
		<updated>2024-09-18T18:24:38Z</updated>

		<summary type="html">&lt;p&gt;Pagină nouă: Pagina dedicata companiei Rocket Pharmaceuticals, Inc. listata cu simbolul US.RCKT  ==Descriere companie== Rocket Pharmaceuticals, Inc. (https://www.rocketpharma.com/) is a clinical-stage, multi-platform biotechnology company that is focused on the development of gene therapies for rare and devastating diseases. The Company’s clinical-stage ex vivo lentiviral vector (LVV) programs include: Fanconi Anemia (FA), is a genetic defect in the bone marrow that reduces production o...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pagină nouă&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Pagina dedicata companiei Rocket Pharmaceuticals, Inc. listata cu simbolul US.RCKT&lt;br /&gt;
&lt;br /&gt;
==Descriere companie==&lt;br /&gt;
Rocket Pharmaceuticals, Inc. (https://www.rocketpharma.com/) is a clinical-stage, multi-platform biotechnology company that is focused on the development of gene therapies for rare and devastating diseases. The Company’s clinical-stage ex vivo lentiviral vector (LVV) programs include: Fanconi Anemia (FA), is a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; Leukocyte Adhesion Deficiency-I (LAD-I), is a genetic disorder that causes the immune system to malfunction; Pyruvate Kinase Deficiency (PKD), is a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia, and Infantile Malignant Osteopetrosis (IMO), is a genetic disorder characterized by increased bone density and bone mass secondary to impaired bone resorption.&lt;br /&gt;
&lt;br /&gt;
==Grafic actiuni companie==&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tradeville&amp;quot; path=&amp;quot;graficSimbol/US.RCKT&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Ultimele stiri despre Rocket Pharmaceuticals, Inc. (US.RCKT)==&lt;br /&gt;
&amp;lt;dynamicpagelist&amp;gt;&lt;br /&gt;
category=US.RCKT&lt;br /&gt;
count=10&lt;br /&gt;
order=descending&lt;br /&gt;
addfirstcategorydate=false&lt;br /&gt;
&amp;lt;/dynamicpagelist&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Categorie:US.RCKT]][[Categorie:Stiri despre companii]]&lt;/div&gt;</summary>
		<author><name>Admin</name></author>
	</entry>
</feed>